? ENRICHMENT PROGRAM The Enrichment Program provides opportunities for education and networking for the Liver Center in four related ways. First, the Program provides Center members with the latest information about their specific areas of interest. Second, the Program seeks to broaden the appreciation that Center members have for related areas of research in liver biology and pathobiology. Third, the Program seeks to enhance collaboration among Center members; in part because of the enrichment program, nearly all Center members collaborate with at least one other Center member and half of all Center-related publications are co-authored by multiple Center members. Finally, the Program serves as an outreach mechanism to non-liver physicians, scientists and lay people to enhance their understanding of liver disease. We have established several mechanisms to achieve these goals. These include (1) a monthly seminar series, (2) an annual retreat, (3) a quarterly newsletter, (4) certain special scientific and educational programs and symposia, (5) an annual visiting professorship program ?reverse mini- sabbatical?, and (6) a website. All Center seminars, conferences, symposia, and newsletters are posted on the Center?s website, which is updated weekly, and advertised via poster and e-mail notification. Through these activities, the Enrichment Program creates opportunities for open discussions of the latest developments in the fields of liver pathophysiology and treatment. The Enrichment Program fosters collaborations, publications and grants by bringing leaders in the most advanced areas of hepatology research to Yale. This represents a particularly valuable opportunity for junior investigators to develop networking, establish relevant collaborations, and obtain access to important and unique reagents and technologies.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
New Haven
United States
Zip Code
Franca, Andressa; Filho, Antonio Carlos Melo Lima; Guerra, Mateus T et al. (2018) Effects of endotoxin on type 3 inositol 1,4,5-trisphosphate receptor in human cholangiocytes. Hepatology :
Liu, Chune; Yang, Zhihong; Wu, Jianguo et al. (2018) Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis. Hepatology 67:1768-1783
Brivio, Simone; Cadamuro, Massimiliano; Fabris, Luca et al. (2018) Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expr 18:31-50
Cox, Carly S; McKay, Sharen E; Holmbeck, Marissa A et al. (2018) Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling. Cell Metab 28:776-786.e5
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Schmitz, Corinna; Noels, Heidi; El Bounkari, Omar et al. (2018) Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J 32:4428-4443
Pan, Qiong; Zhang, Xiaoxun; Zhang, Liangjun et al. (2018) Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155:1578-1592.e16
Jakab, Sofia Simona; Garcia-Tsao, Guadalupe (2018) Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol :
Fiorotto, Romina; Amenduni, Mariangela; Mariotti, Valeria et al. (2018) Src kinase inhibition reduces inflammatory and cytoskeletal changes in ?F508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 67:972-988
Sari, Sinan; Dalgic, Buket; Muehlenbachs, Atis et al. (2018) Prototheca zopfii Colitis in Inherited CARD9 Deficiency. J Infect Dis 218:485-489

Showing the most recent 10 out of 763 publications